Reuters logo
BRIEF-Janssen receives approval for Tremfya in Europe - Morphosys
November 23, 2017 / 9:26 AM / 25 days ago

BRIEF-Janssen receives approval for Tremfya in Europe - Morphosys

Nov 23 (Reuters) - Morphosys AG

* Announces that its licensee Janssen has received approval for Tremfya(r) (guselkumab) in Europe for the treatment of moderate-to-severe plaque psoriasis

* Says is ‍entitled to royalties on net sales of Janssen’s Tremfya​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below